Steris Corp (NYSE:STE) Shares Were Downgraded Today by Raymond James

April 23, 2018 - By Richard Conner

STERIS plc (NYSE:STE) Logo

Investors sentiment decreased to 0.17 in 2017 Q4. Its down 0.33, from 0.5 in 2017Q3. It turned negative, as 4 investors sold STERIS plc shares while 2 reduced holdings. 1 funds opened positions while 0 raised stakes. 19,649 shares or 85.67% less from 137,131 shares in 2017Q3 were reported.

Prudential Pcl owns 3,800 shares. Alphamark Advisors Limited Liability Company owns 150 shares. Fruth Mngmt accumulated 14,076 shares or 0.52% of the stock. Hanson And Doremus Inv accumulated 1,500 shares. 123 were reported by Shine Advisory Svcs.

Steris Corp (NYSE:STE) Receives a Downgrade

In a note issued on Wednesday morning, Raymond James revealed that they have decided to downgrade shares of Steris Corp (NYSE:STE) to a Hold.

Investors sentiment decreased to 0.17 in 2017 Q4. Its down 0.33, from 0.5 in 2017Q3. It turned negative, as 4 investors sold STERIS plc shares while 2 reduced holdings. 1 funds opened positions while 0 raised stakes. 19,649 shares or 85.67% less from 137,131 shares in 2017Q3 were reported.

Prudential Pcl owns 3,800 shares. Alphamark Advisors Limited Liability Company owns 150 shares. Fruth Mngmt accumulated 14,076 shares or 0.52% of the stock. Hanson And Doremus Inv accumulated 1,500 shares. 123 were reported by Shine Advisory Svcs.

STERIS plc (NYSE:STE) Ratings Coverage

Among 3 analysts covering Steris Corp (NYSE:STE), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Steris Corp has $103.0 highest and $101.0 lowest target. $101.67’s average target is 5.86% above currents $96.04 stock price. Steris Corp had 4 analyst reports since November 2, 2017 according to SRatingsIntel. On Thursday, November 2 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. As per Thursday, February 8, the company rating was maintained by KeyBanc Capital Markets. The rating was maintained by Northcoast on Thursday, February 8 with “Buy”. On Wednesday, January 3 the stock rating was downgraded by Raymond James to “Market Perform”.

The stock decreased 0.19% or $0.18 during the last trading session, reaching $96.04. About 228,633 shares traded. STERIS plc (NYSE:STE) has risen 32.31% since April 23, 2017 and is uptrending. It has outperformed by 20.76% the S&P500.

Analysts await STERIS plc (NYSE:STE) to report earnings on May, 8. They expect $1.22 earnings per share, up 9.91 % or $0.11 from last year’s $1.11 per share. STE’s profit will be $103.52 million for 19.68 P/E if the $1.22 EPS becomes a reality. After $1.12 actual earnings per share reported by STERIS plc for the previous quarter, Wall Street now forecasts 8.93 % EPS growth.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide. The company has market cap of $8.15 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It has a 33.83 P/E ratio. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

STERIS plc (NYSE:STE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.